Unravelling Effectiveness of a Nurse-led Behavior Change Intervention to Enhance Physical Activity in Patients

Sponsor
UMC Utrecht (Other)
Overall Status
Completed
CT.gov ID
NCT02725203
Collaborator
ZonMw: The Netherlands Organisation for Health Research and Development (Other)
195
31
2
20
6.3
0.3

Study Details

Study Description

Brief Summary

A two-armed, cluster randomized controlled trial will be conducted comparing the Activate intervention with care as usual in 31 general practices in the Netherlands, in which approximately 279 patients at risk for cardiovascular disease will participate. The Activate intervention focuses on increasing physical activity and is developed using the Behavior Change Wheel (BCW). The activate intervention consists of four nurse-led consultations divided over a 3-months period. Primary outcome is the level of physical activity measured with an accelerometer. Potential effect modifiers are age, body mass index, level of education, social support, depression, patient-provider relationship and baseline amount of minutes of physical activity. Data will be collected at baseline, at 3 months and at 6 months of follow up.

Nurses will be trained in delivering the intervention by a one-day training and coaching sessions supervised. A process evaluation will be conducted.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Activate
N/A

Detailed Description

Self-management interventions are considered effective in chronic disease patients, but trials have shown inconsistent results and it is unknown which patients benefit most. Adequate self-management requires behaviour change in patients and in healthcare providers to equip them in supporting patients in changing their behaviour. To unravel effectiveness of self-management, a nurse-led intervention was developed targeting at one self-management behaviour, namely physical activity, in primary care patients at risk for cardiovascular disease: the Activate intervention. This study aims to evaluate the effectiveness of the Activate intervention, to identify which patient-related characteristics modify change in physical activity levels in patients at risk for CVD in primary care, and to conduct a process evaluation.

A two-armed, cluster randomized controlled trial will be conducted comparing the Activate intervention with care as usual in 31 general practices in the Netherlands, in which approximately 300 patients at risk for cardiovascular disease will participate. The Activate intervention focuses on increasing physical activity and is developed using the Behavior Change Wheel (BCW). The activate intervention consists of four nurse-led consultations divided over a 3-months period in which 17 behaviour change techniques (BCTs) are integrated. Primary outcome is the level of physical activity measured with an accelerometer . Potential effect modifiers are age, body mass index, level of education, social support, depression, patient-provider relationship and baseline amount of minutes of physical activity. Data will be collected at baseline, at 3 months and at 6 months of follow up.

Subsequently, the BCW was applied to analyse what behavior change is needed in nurses to deliver the Activate intervention adequately. This resulted in a one-day training and coaching sessions supervised by a health psychologist and included 21 BCT.

A process evaluation will be conducted to evaluate the training of nurses, fidelity, dose and reach of the Activate intervention, identify barriers and facilitators for implementation and to assess participants' satisfaction.

Study Design

Study Type:
Interventional
Actual Enrollment :
195 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Unravelling Effectiveness of a Nurse-led Behavior Change Intervention to Enhance Physical Activity in Patients With a Cardiovascular Risk: a Clustered-randomized Controlled Trial in Primary Care
Study Start Date :
Mar 1, 2016
Actual Primary Completion Date :
Nov 1, 2017
Actual Study Completion Date :
Nov 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention: Activate intervention

Participants in the intervention arm will visit their primary care nurse four times in a three-month period for structured and comprehensive support in achieving an improved level of physical activity.

Behavioral: Activate
The Activate intervention consists of four nurse-led consultations in a thee-month period. In the consultations patients receive structured and comprehensive support in achieving an improved level of physical activity. The Behavior Change Wheel was used to develop the Activate intervention, and led to a selection of 17 behavior change techniques, which are integrated in the Activate intervention

No Intervention: Control

Patients in the control arm will receive care as usual.

Outcome Measures

Primary Outcome Measures

  1. level of physical activity measured with the Personal Activity Monitor (PAM AM300) [baseline - 6 months of follow up]

    The amount of minutes of physical activity in the moderate (3-6 METabolic equivalent (METS)) and vigorous categories (≥6 METS) at 6 months of follow up will be considered as primary outcome measure. Patients will be asked to wear the accelerometer during 7 consecutive days for 12 hours a day at baseline (T0), 3 months of follow up (T1) and at 6 months of follow up (T2).

Secondary Outcome Measures

  1. Sedentary behaviour using the accelerometer using amount of minutes in the sedentary category (<1,8 METS) [baseline -3 months and 6 months of follow up]

    Sedentary behaviour using the accelerometer using amount of minutes in the sedentary category (<1,8 METS)

  2. Self-efficacy for physical activity using the Exercise Self-efficacy Scale (ESS) [baseline - 3 months and 6 months of follow up]

    Self-efficacy for physical activity using the Exercise Self-efficacy Scale (ESS), baseline, T0, T1, T2

  3. Patient activation using the Patient Activation Measure (PAM-13) [baseline -3 months and 6 months of follow up]

    Patient activation using the Patient Activation Measure (PAM-13)

  4. Health status using the EQ-5D [baseline - 6 months of follow up]

    Health status using the EQ-5D

Other Outcome Measures

  1. Potential effect modifier: age [baseline]

    does age modify change in physical activity level

  2. Potential effect modifier: depression using the Hospital Anxiety and Depression Scale (HADS) [baseline]

    does depression modify change in physical activity level

  3. Potential effect modifier: Body Mass Index (BMI) [baseline]

    does BMI modify change in physical activity level

  4. Potential effect modifier: level of education [baseline]

    does education level modify change in physical activity

  5. Potential effect modifier: social support using Multidimensional Scale of Perceived Social Support (MSPSS) [baseline,]

    does social support modify change in level of physical activity

  6. Potential effect modifier: patient-provider relationship using the Communication Assessment Tool (CAT) [baseline, 3 months and 6 months of follow up]

    does the patient-provider relationship modify change in level of physical activity

  7. Potential effect modifier: baseline amount of minutes of moderate to vigorous level of physical activity using the PAM AM300 [baseline]

    does baseline amount of minutes of moderate to vigorous level of physical activity modify change in level of physical activity

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Aged 40-75

AND at least one of the following criteria:
  • have a high blood pressure (≥ 140 mmHg) or are already treated for high blood pressure

  • have a high total cholesterol (≥ 6.5 mmol/l) or already treated for high cholesterol

  • have diabetes mellitus type 2 (DM2)

  • have a positive family history of CVD AND Do not meet the Dutch Norm for Healthy Exercise according to the Short QUestionnaire to Asses Health (SQUASH).

Exclusion Criteria:
  • unable to give informed consent (eg. due to cognitive impairment),

  • unable to speak, write and read Dutch,

  • have contra-indications to increase their physical activity level (eg. unstable angina pectoris, unstable heart failure, acute illness)

  • have a terminal illness or have severe psychiatric illness or chronic disorder(s) that seriously influence the ability to improve their psychical activity level.

  • patients should not have participated in a program to increase their level of physical activity in the past 2 years.

Contacts and Locations

Locations

Site City State Country Postal Code
1 GP Lienderweg Asten Brabant Netherlands 5721CM
2 GP Timmerman Drunen Brabant Netherlands 5151 HA
3 GP Emmers s Hertogenbosch Brabant Netherlands 5235KG
4 GP Klaar and Vincent Ede Gelderland Netherlands 6713 NS
5 GP Parklaan Hoevelaken Gelderland Netherlands 3871EE
6 GP Buren Buren Gerlderland Netherlands 4116CW
7 GP Seinhorst Hilversum Noord Holland Netherlands 1223DT
8 GP Tjin a Ton and Parlevliet Amstelveen Noord-Holland Netherlands 1186PJ
9 GP De Kennemerpoort Bennebroek Noord-Holland Netherlands 2121BB
10 GP Odijk-Visser Heerhugowaard Noord-Holland Netherlands 1701 ER
11 GP Munster Heerhugowaard Noord-Holland Netherlands 1701ER
12 GP Eedenburgh Hilversum Noord-Holland Netherlands 1215EK
13 GP Koedijk Koedijk Noord-Holland Netherlands 1831EK
14 GP De Hollenhorst Nieuw Vennep Noord-Holland Netherlands 2152CA
15 GP Spelt Wassenaar Noord-Holland Netherlands 2241KE
16 GP Jonker Colmschate Overijssel Netherlands 7429BG
17 GP Amarant Kampen Overijssel Netherlands 8265 DN
18 GP Rosing and Bruins Slot Markelo Overijssel Netherlands 7475AG
19 GP Blanker, Thiele, Brand Zwolle Overijssel Netherlands 8042AD
20 GP Provostlaan Bilthoven Utrecht Netherlands 3723RC
21 GP van Steenis Bunnik Utrecht Netherlands 3981EV
22 GP De Bilt De BIlt Utrecht Netherlands 3732BG
23 GP Tolgaarde Leusden Utrecht Netherlands 3831JR
24 GP Odijk Odijk Utrecht Netherlands 3984MA
25 GP De Schans Woudenberg Utrecht Netherlands 3931 KJ
26 GP Sparreboom Alphen aan den Rijn Zuid-Holland Netherlands 2408 LA
27 GP Wiechen Boskoop Zuid-Holland Netherlands 2771 EN
28 GP De Wiel Schoonrewoerd Zuid-Holland Netherlands 4145NV
29 GP Mozaiek The Hague Zuid-Holland Netherlands 2525CE
30 GP Loudon The Hague Zuid-Holland Netherlands 2593WB
31 GP Lombok Utrecht Netherlands 3531 HX

Sponsors and Collaborators

  • UMC Utrecht
  • ZonMw: The Netherlands Organisation for Health Research and Development

Investigators

  • Study Chair: Marieke J. Schuurmans, PhD, UMC Utrecht
  • Principal Investigator: Heleen Westland, MSc, UMC Utrecht
  • Principal Investigator: Irene D Bos-Touwen, MSc, UMC Utrecht
  • Study Chair: Jaap CA Trappenburg, PhD, UMC Utrecht
  • Study Chair: Carin D Schröder, PhD, UMC Utrecht

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
H.Westland, RN, MSc, UMC Utrecht
ClinicalTrials.gov Identifier:
NCT02725203
Other Study ID Numbers:
  • NL54286.041.15
First Posted:
Mar 31, 2016
Last Update Posted:
Oct 18, 2018
Last Verified:
Oct 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by H.Westland, RN, MSc, UMC Utrecht
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 18, 2018